Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Other financing activities (2019 - 2026)

Strata Critical Medical (SRTA) reported Other financing activities of $329000.0 for Q1 2026, down 24.87% on a QoQ basis from $437880.0 in Q4 2019.

Strata Critical Medical (SRTA) has 2 years of Other financing activities data on file, last reported at $329000.0 in Q1 2026.

  • Quarterly Other financing activities changed N/A year-over-year to $329000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 32.96% YoY) and the FY2019 annual result came in at $410880.0, changed N/A from the prior year.
  • Other financing activities declined to $329000.0 in Q1 2026 per SRTA's latest filing, from $437880.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $329000.0 in Q1 2026 and bottomed at $329000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Strata Critical Medical 538.39 Mn 479.60 Mn 14.12 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 329,000.00
Mar 31, 2026 329,000.00
Dec 31, 2019 437,880.00
Dec 31, 2019 437,880.00
Sep 30, 2019 410,880.00
Sep 30, 2019 410,880.00
Jun 30, 2019 37,024.00
Jun 30, 2019 37,024.00